Oral manifestations of immune‐related adverse events in cancer patients treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Oral manifestations of immune‐related adverse events in cancer patients treated with immune checkpoint inhibitors

Published:2021-08-03 Issue:1 Volume:28 Page:9-22
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Diseases

Author:

Klein Brittany A.¹²^ORCID,Alves Fábio Abreu³⁴^ORCID,Santana Rodrigues Velho Julia⁴,Vacharotayangul Piamkamon¹²,Hanna Glenn J.⁵,LeBoeuf Nicole R.⁶,Shazib Muhammad Ali⁷,Villa Alessandro⁸^ORCID,Woo Sook‐Bin¹²,Sroussi Hervé¹²,Sonis Stephen¹²,Treister Nathaniel S.¹²^ORCID

Affiliation:

1. Division of Oral Medicine and Dentistry Brigham and Women’s Hospital Boston MA USA

2. Harvard School of Dental Medicine Boston MA USA

3. A.C. Camargo Cancer Center São Paulo Brazil

4. University of São Paulo School of Dentistry São Paulo Brazil

5. Center for Head and Neck Oncology Dana‐Farber Cancer Institute Boston MA USA

6. Department of Dermatology Center for Cutaneous Oncology Dana‐Farber/Brigham and Women’s Cancer Center Harvard Medical School Boston MA USA

7. Division of Craniofacial and Surgical Care University of North Carolina at Chapel Hill Adams School of Dentistry Chapel Hill NC USA

8. Department of Orofacial Sciences University of California San Francisco San Francisco CA USA

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.13964

Reference83 articles.

1. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab

2. Erythema Multiforme With Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders With Distinct Causes

3. A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication

4. Severe oral erosive lichenoid reaction to pembrolizumab therapy

5. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral complications from head and neck cancer therapy;Head and Neck Cancer Rehabilitation;2025

2. Imiquimod for the treatment of oral leukoplakia: A two‐center retrospective study;Oral Diseases;2024-07-15

3. Assessing the knowledge and awareness of US oncologists regarding the specialty of oral medicine;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-07

4. Oral and cutaneous immune‐related adverse events in cancer patients: Prevalence and overall survival;Oral Diseases;2024-06-27

5. Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management;Expert Review of Clinical Immunology;2024-06-25